Healthcare

HB 14 extends the expiration date for Utah's Behavior Analyst Licensing Act from July 1, 2026, to July 1, 2036. This change ensures the law governing behavior analyst licensure remains in effect for an additional decade, preventing its automatic repeal. The bill includes minor technical adjustments to the relevant code but does not alter licensing requirements for behavior analysts. This extension directly affects behavior analysts and the state's regulatory process for their professional licensing.

HB 356 clarifies Utah's rules for the federal 340B drug discount program, which provides discounted medications to eligible healthcare organizations. It defines key terms like "340B covered entity" (e.g., hospitals or clinics participating in the federal program) and prohibits drug manufacturers from restricting contracts between pharmacies and these entities or requiring excessive data sharing beyond federal requirements. The bill directly affects 340B-covered entities, pharmacies, and drug manufacturers by ensuring they cannot interfere with program participation or impose unnecessary conditions. It makes technical updates to Utah law without new funding, aligning state rules with federal program standards.